FDA Fast Track

BOCA RATON, Fla., May 15, 2026 INmune Bio announced the publication of positive Phase 2 MINDFuL trial results for...

DURHAM, N.C., May 11, 2026 AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary...

LONDON, UK – May 11, 2026 GSK plc announced an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group) through...

SAN FRANCISCO and SUZHOU, China, May 10, 2026 Innovent Biologics, Inc. announced that China’s National Medical Products Administration (NMPA)...

MELVILLE, N.Y., May 7, 2026 BioRestorative Therapies announced expanded blinded Phase 2 clinical data for BRTX-100, its investigational autologous...

CAMBRIDGE, Mass., May 6, 2026 Clear Scientific Inc., a clinical-stage biopharmaceutical company developing innovative therapies for acute drug intoxication,...

HOUSTON, May 6, 2026 Diakonos Oncology Corp., a clinical-stage biotechnology company focused on next-generation cancer immunotherapies, has announced that...

BOTHELL, Wash., April 30, 2026 Cocrystal Pharma, Inc., a clinical-stage biotechnology company focused on antiviral therapeutics, has presented new...

PARSIPPANY, NEW JERSEY & CHICAGO, April 29, 2026 Teva Pharmaceutical Industries Ltd. has announced a definitive agreement to acquire...

WALTHAM, Mass., April 28, 2026 Affinia Therapeutics has announced new progress for AFTX-201, its lead investigational gene therapy for...